Healthcare
Why Caladrius Biosciences (CLBS) Stock Is Significantly Undervalued
Those that follow my articles know that I tend to focus mainly on undervalued microcap …
Are These Two Healthcare Stocks Great Bargains? Analysts Say Yes
By Harriet Lefton You don’t need to spend big to pick up premium stock picks… …
3 Biotechs with Upcoming Data to Watch
Written by Dan Cohen and Scott Matusow Cytokinetics (NASDASQ:CYTK) looks to turn around their fortunes …
Abbvie (ABBV): A Top Winning Stock to Buy
By Amber Hestla This past weekend, I had a chance to talk to a friend …
Recent Sell-Off in Jounce therapeutics’ (JNCE) Stock Is Unwarranted
Written by Dan Cohen In the wake of recently revealed abstracts from the 2018 ASCO …
Omeros (OMER) Stock Could Become a 10-Bagger
By Richard Robinson Many Americans are optimistic about achieving a comfortable retirement. They fund their 401(k) …
Hedge Fund Tycoon David Shaw Makes 2 Risky Bio Bets: MannKind Corporation (MNKD), Valeant Pharmaceuticals Intl Inc (VRX)
Chief scientist Shaw looks for unusual sources of return in MNKD and VRX.
Can Synergy Pharmaceuticals Inc Get Things Moving Again with Trulance?
Wednesday could mark a turning point for Synergy investors.
4 Biotechs with Near Term Catalysts: G1 Therapeutics, Inc. (GTHX), Sierra Oncology Inc (SRRA), Myokardia Inc (MYOK), Jounce Therapeutics (JNCE)
Written by Danny Cohen and Scott Matusow The biotech “run-up” trade has always attracted a …
A Growing Medical Device Player Aiming to Rule the $6.3 Billion Pain Market; An Exclusive Interview with Zynex CEO Thomas Sandgaard
Before founding Zynex, Inc. (OTCMKTS:ZYXI) over two decades ago, Thomas Sandgaard was a man who …
